Repopulation of Cancer Cells During Therapy: an Important Cause of Treatment Failure

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2005 Jun 21

PMID 15965493

Citations 267

Authors

John J Kim

Ian F Tannock

Affiliations

Soon will be listed here.

Abstract

Radiotherapy and chemotherapy are given in multiple doses, which are spaced out to allow the recovery of normal tissues between treatments. However, surviving cancer cells also proliferate during the intervals between treatments and this process of repopulation is an important cause of treatment failure. Strategies developed to overcome repopulation have improved clinical outcomes, and now new strategies to inhibit repopulation are emerging in parallel with advances in the understanding of underlying biological mechanisms.

Citing Articles

LPA released from dying cancer cells after chemotherapy inactivates Hippo signaling and promotes pancreatic cancer cell repopulation.

Liu Y, Ding J, Li S, Jiang A, Chen Z, Quan M Cell Oncol (Dordr). 2025; .

PMID: 39903418 DOI: 10.1007/s13402-025-01038-9.

Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers.

Wang S, Bai Y, Ma J, Qiao L, Zhang M Front Pharmacol. 2024; 15:1442227.

PMID: 39512820 PMC: 11540796. DOI: 10.3389/fphar.2024.1442227.

The association between initiation weekday of radiotherapy and local control in stage 1 glottic carcinoma: a retrospective analysis.

Endo M, Takahashi S, Fukuda Y, Okada K, Ogawa K, Nakamura M J Radiat Res. 2024; 65(6):798-804.

PMID: 39287117 PMC: 11630084. DOI: 10.1093/jrr/rrae074.

Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells.

Shender V, Anufrieva K, Shnaider P, Arapidi G, Pavlyukov M, Ivanova O Nat Commun. 2024; 15(1):5237.

PMID: 38898005 PMC: 11187153. DOI: 10.1038/s41467-024-49512-6.

Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation.

Jiang M, Lin C, Liu F, Mei Z, Gu D, Tian L Heliyon. 2024; 10(10):e31346.

PMID: 38807872 PMC: 11130661. DOI: 10.1016/j.heliyon.2024.e31346.